Therapeutic strategies for afatinib ‐resistant lung cancer harboring HER2 alterations
This article is protected by copyright. All rights reserved.
Source: Cancer Science - Category: Cancer & Oncology Authors: Hidejiro Torigoe, Kazuhiko Shien, Tatsuaki Takeda, Takahiro Yoshioka, Kei Namba, Hiroki Sato, Ken suzawa, Hiromasa Yamamoto, Junichi Soh, Masakiyo Sakaguchi, Shuta Tomida, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Docetaxel | Gastric (Stomach) Cancer | Gastroenterology | Genetics | HER2 | Lung Cancer | Non-Small Cell Lung Cancer | Science | Stem Cell Therapy | Stem Cells | Study | Taxotere